Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles.

Lin Q, Chen J, Ng KK, Cao W, Zhang Z, Zheng G.

Pharm Res. 2014 Jun;31(6):1438-49. doi: 10.1007/s11095-013-1046-z. Epub 2013 Apr 27.

PMID:
23625096
2.

Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.

Nieland TJ, Penman M, Dori L, Krieger M, Kirchhausen T.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15422-7. Epub 2002 Nov 18.

3.

Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles.

Lin Q, Chen J, Jin H, Ng KK, Yang M, Cao W, Ding L, Zhang Z, Zheng G.

Nanomedicine (Lond). 2012 Dec;7(12):1813-25. doi: 10.2217/nnm.12.73. Epub 2012 Jul 26.

PMID:
22830501
4.

Localization and regulation of SR-BI in membrane rafts of HepG2 cells.

Rhainds D, Bourgeois P, Bourret G, Huard K, Falstrault L, Brissette L.

J Cell Sci. 2004 Jul 1;117(Pt 15):3095-105.

5.

Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells.

Urban S, Zieseniss S, Werder M, Hauser H, Budzinski R, Engelmann B.

J Biol Chem. 2000 Oct 27;275(43):33409-15.

6.

Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products.

Ohgami N, Nagai R, Miyazaki A, Ikemoto M, Arai H, Horiuchi S, Nakayama H.

J Biol Chem. 2001 Apr 20;276(16):13348-55. Epub 2001 Jan 17.

7.

Visualization of the uptake of individual HDL particles in living cells via the scavenger receptor class B type I.

Rhode S, Breuer A, Hesse J, Sonnleitner M, Pagler TA, Doringer M, Sch├╝tz GJ, Stangl H.

Cell Biochem Biophys. 2004;41(3):343-56.

PMID:
15509885
8.
9.

Lipoprotein binding preference of CD36 is altered by filipin treatment.

Zhang J, Chu W, Crandall I.

Lipids Health Dis. 2008 Jun 26;7:23. doi: 10.1186/1476-511X-7-23.

10.

The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Marsche G, Frank S, Raynes JG, Kozarsky KF, Sattler W, Malle E.

Biochem J. 2007 Feb 15;402(1):117-24.

11.
12.

Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.

de Beer MC, Durbin DM, Cai L, Mirocha N, Jonas A, Webb NR, de Beer FC, van Der Westhuyzen DR.

J Biol Chem. 2001 May 11;276(19):15832-9. Epub 2001 Feb 9.

13.
14.
15.

Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.

Zheng Y, Liu Y, Jin H, Pan S, Qian Y, Huang C, Zeng Y, Luo Q, Zeng M, Zhang Z.

Theranostics. 2013 Jun 25;3(7):477-86. doi: 10.7150/thno.6617. Print 2013.

16.

Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model.

Balazs Z, Panzenboeck U, Hammer A, Sovic A, Quehenberger O, Malle E, Sattler W.

J Neurochem. 2004 May;89(4):939-50.

17.

Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism.

Rinninger F, Wang N, Ramakrishnan R, Jiang XC, Tall AR.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1325-32.

18.

Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake.

Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR.

J Biol Chem. 2005 Jan 28;280(4):2954-61. Epub 2004 Nov 23.

19.

SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells.

Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC, van der Westhuyzen DR.

J Biol Chem. 1998 Jun 12;273(24):15241-8.

20.

Interaction of scavenger receptor class B type I with peroxisomal targeting receptor Pex5p.

Johnson MS, Johansson JM, Svensson PA, Aberg MA, Eriksson PS, Carlsson LM, Carlsson B.

Biochem Biophys Res Commun. 2003 Dec 26;312(4):1325-34.

PMID:
14652019

Supplemental Content

Support Center